Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 12/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 11/20 | 0.39 |
| ▸ | CSNK2B | P67870 | 11/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.39 |
| ▸ | DYRK3 | O43781 | 4/20 | 0.39 |
| ▸ | CDK2 | P24941 | 3/20 | 0.39 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.37 |
| ▸ | DYRK2 | Q92630 | 3/20 | 0.37 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.37 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.37 |
| ▸ | HIPK1 | Q86Z02 | 1/20 | 0.37 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.37 |
| ▸ | HIPK3 | Q9H422 | 1/20 | 0.37 |
| ▸ | DYRK4 | Q9NR20 | 1/20 | 0.37 |
| ▸ | DAPK2 | Q9UIK4 | 1/20 | 0.37 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2358803 | 0.85 | CSNK2A1 (0.49) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL3309971 | 0.83 | CSNK2A2 (0.42) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL12012939 | 0.80 | EGFR (0.41) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL3313747 | 0.78 | FLT3 (0.39) | CSNK2A1CSNK2A2EGLN2 | |
| SCHEMBL13421572 | 0.76 | KCNH2 (0.44) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL3313444 | 0.76 | KCNH2 (0.48) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL2309711 | 0.76 | CSNK2A2 (0.40) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL15084633 | 0.75 | RPS27 (0.44) | CSNK2A1CSNK2A2 | |
| SCHEMBL2358275 | 0.75 | TYK2 (0.35) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 | |
| SCHEMBL12013395 | 0.75 | CSNK2A1 (0.50) | CSNK2A1CSNK2A2CSNK2BKCNH2DYRK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8252795-B2 | Imidazopyridazinecarbonitriles useful as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-08-28 | — | — | US | disclosed |
| US-20100113458-A1 | IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113458-A1 | IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | MAP3K5, MAP3K15, MAP4K2 | CSNK2A1 88/4885CSNK2A2 135/4885CSNK2B 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.